144 related articles for article (PubMed ID: 1873794)
21. Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells.
Devi GR; Oldenkamp JR; London CA; Iversen PL
Prostate; 2002 Nov; 53(3):200-10. PubMed ID: 12386920
[TBL] [Abstract][Full Text] [Related]
22. The therapeutic potential of antisense oligonucleotides.
Sharma HW; Narayanan R
Bioessays; 1995 Dec; 17(12):1055-63. PubMed ID: 8634067
[TBL] [Abstract][Full Text] [Related]
23. Antisense therapy for cancer.
Gleave ME; Monia BP
Nat Rev Cancer; 2005 Jun; 5(6):468-79. PubMed ID: 15905854
[TBL] [Abstract][Full Text] [Related]
24. [Human oncogenes].
Barbacid M
Rev Clin Esp; 1986 Nov; 179(8):412-27. PubMed ID: 3550930
[No Abstract] [Full Text] [Related]
25. Antisense of oligonucleotides and the inhibition of oncogene expression.
Prins J; de Vries EG; Mulder NH
Clin Oncol (R Coll Radiol); 1993; 5(4):245-52. PubMed ID: 8398922
[TBL] [Abstract][Full Text] [Related]
26. Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides.
Hélène C
Eur J Cancer; 1991; 27(11):1466-71. PubMed ID: 1835863
[TBL] [Abstract][Full Text] [Related]
27. Antisense approaches to cancer gene therapy.
Mercola D; Cohen JS
Cancer Gene Ther; 1995 Mar; 2(1):47-59. PubMed ID: 7621254
[TBL] [Abstract][Full Text] [Related]
28. [Basics of antisense oligonucleotide therapy and current therapeutical strategies in urology].
Kausch I; Böhle A
Aktuelle Urol; 2003 Dec; 34(7):458-68. PubMed ID: 14655082
[TBL] [Abstract][Full Text] [Related]
29. Patterns of regulation of nuclear proto-oncogenes MYCN and MYB in retinoic acid treated neuroblastoma cells.
Thiele CJ
Prog Clin Biol Res; 1991; 366():151-6. PubMed ID: 2068135
[No Abstract] [Full Text] [Related]
30. Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines.
Van Waardenburg RC; Prins J; Meijer C; Uges DR; De Vries EG; Mulder NH
Anticancer Res; 1996; 16(4A):1963-70. PubMed ID: 8712728
[TBL] [Abstract][Full Text] [Related]
31. Heart-specific inhibition of protooncogene c-myc attenuates cold-induced cardiac hypertrophy.
Bello Roufai M; Li H; Sun Z
Gene Ther; 2007 Oct; 14(19):1406-16. PubMed ID: 17637797
[TBL] [Abstract][Full Text] [Related]
32. Antisense oligonucleotides as therapeutics for malignant diseases.
Ho PT; Parkinson DR
Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
Cucco C; Calabretta B
Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118
[TBL] [Abstract][Full Text] [Related]
34. Protooncogene activation in spontaneously occurring and chemically induced rodent and human lung tumors.
Reynolds SH; Wiest JS; Devereux TR; Anderson MW; You M
Prog Clin Biol Res; 1992; 376():303-20. PubMed ID: 1528924
[No Abstract] [Full Text] [Related]
35. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT.
Makover D; Cuddy M; Yum S; Bradley K; Alpers J; Sukhatme V; Reed JC
Oncogene; 1991 Mar; 6(3):455-60. PubMed ID: 2011401
[TBL] [Abstract][Full Text] [Related]
36. Antisense oligodeoxynucleotides for the treatment of chronic myelogenous leukemia: are they still a promise?
de Fabritiis P; Calabretta B
Haematologica; 1995; 80(4):295-9. PubMed ID: 7590496
[No Abstract] [Full Text] [Related]
37. Reduction of cisplatin cytotoxicity on human lung cancer cell lines with N-myc amplification by pretreatment with N-myc antisense oligodeoxynucleotides.
Mizushima Y; Kashii T; Kobayashi M
Anticancer Res; 1995; 15(1):37-43. PubMed ID: 7733638
[TBL] [Abstract][Full Text] [Related]
38. C-myc antisense oligodeoxynucleotides can induce apoptosis and down-regulate Fas expression in rheumatoid synoviocytes.
Hashiramoto A; Sano H; Maekawa T; Kawahito Y; Kimura S; Kusaka Y; Wilder RL; Kato H; Kondo M; Nakajima H
Arthritis Rheum; 1999 May; 42(5):954-62. PubMed ID: 10323451
[TBL] [Abstract][Full Text] [Related]
39. Specific inhibition of oncogene expression in vitro and in vivo by antisense oligonucleotides.
Neckers L; Rosolen A; Fahmy B; Whitesell L
Ann N Y Acad Sci; 1992 Oct; 660():37-44. PubMed ID: 1340154
[No Abstract] [Full Text] [Related]
40. Antitumor effects of antisense phosphorothioate c-myc oligodeoxynucleotides: a question of mechanism.
Stein CA
J Natl Cancer Inst; 1996 Apr; 88(7):391-3. PubMed ID: 8618230
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]